Therapure Biopharma Inc
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.therapurebio.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Phase 1
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2019-04-09
- Last Posted Date
- 2019-04-09
- Lead Sponsor
- Therapure Biopharma Inc
- Target Recruit Count
- 12
- Registration Number
- NCT03908840
- Locations
- 🇺🇸
Indiana University Simon Cancer Center, Indianapolis, Indiana, United States
Study of PlasmaCap IG in Adults and Children With PIDD
Phase 3
- Conditions
- Primary Immune Deficiency Diseases (PIDD)
- First Posted Date
- 2017-08-03
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- Therapure Biopharma Inc
- Target Recruit Count
- 74
- Registration Number
- NCT03238079
- Locations
- 🇺🇸
University of California, Los Angeles, California, United States
🇺🇸IMMUNOe Health & Research Centers, Centennial, Colorado, United States
🇺🇸University of South Florida, Tampa, Florida, United States
News
No news found